Antisense homology box-derived peptides represent a new class of endothelin receptor inhibitors

Peptides

Volumn 19, Issue 2, 1998, Pages 211-223

  Baranyi, Lajos ^a,b   Campbell, William ^a,b   Ohshima, Kunihiro ^b   Fujimoto, Seigo ^b   Boros, Mihály ^c   Kaszaki, József ^c   Okada, Hidechika ^b  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Antagonist; Antisense homology box; Complementary peptide; Endothelin receptor; Hydropathic complementarity; Inverse agonist

Indexed keywords

AMINO ACID; CALCIUM ION; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; PEPTIDE; PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; COMPUTER PROGRAM; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC CODE; MALE; MOUSE; NONHUMAN; NUCLEIC ACID PROBE; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SEQUENCE HOMOLOGY; SMOOTH MUSCLE RELAXATION;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; CALCIUM; CATTLE; DNA, ANTISENSE; DOGS; ENDOTHELIN-1; HUMANS; ION TRANSPORT; MALE; MICE; MOLECULAR SEQUENCE DATA; MUSCLE RELAXATION; PEPTIDE MAPPING; PEPTIDES; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN; SEQUENCE HOMOLOGY, AMINO ACID; SOFTWARE;

ANIMALIA;

EID: 0032005892     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00370-7     Document Type: Article

References (36)

1. Shiosaki K., Tasker A. S., Sullivan G. M., Sorensen B. K., von Geldern T. W., Wu-Wong J. R., Marselle C. A., Opgenorth T. J. Potent and selective inhibitors of an aspartyl protease-like endothelin converting enzyme identified in rat lung. J. Med. Chem. 36:1993;468-478.
2. Arai H., Hori S., Aramori I., Ohkubo H., Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 348:1990;730-732.
3. Sakurai T., Yanagisawa M., Takuwa Y., Miyazaki H., Kimura S., Goto K., Masaki T. Cloning of a cDNA encoding a non-isopeptide selective subtype of the endothelin receptor. Nature. 348:1990;732-735.
4. Sakamoto A., Yanagisawa M., Sawamura T., Enoki T., Ohtani T., Sakurai T., Nakao K., Toyo-oka T., Masaki T. Distinct subdomains of human endothelin receptors determine their selectivity to endothelin A-selective antagonist and endothelin B-selective agonists. J. Biol. Chem. 268:1993;8547-8553.
5. B receptors mediate contraction to endothelin-1 in human blood vessels. Circulation. 89:1994;1203-1208.
6. Bax W. A., Saxena P. R. The current endothelin classification time for reconsideration? TIBS. 15:1994;379-385.
7. Gellai M. Physiological role of endothelin in cardiovascular and renal hemodynamics studies in animals . Curr. Opin. Nephrol. Hypertens. 6:1997;64-68.
8. 2-terminal kinase groups of mitogen-activated protein kinases. J. Biol. Chem. 271:1996;5750-5754.
9. Wilkins F. C. Jr, Alberola A., Mizelle H. L., Opgenorth T. J., Granger J. P. Systemic hemodynamics and renal function during long-term pathophysiological increases in circulating endothelin. Am. J. Physiol. 268:1995;375-381.
10. Clozel M., Breu V., Burri K., Cassal J. M., Fischli W., Gray G. A., Hirth G., Loffler B. M., Muller M., Neidhart W. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature. 365:1993;759-761.
11. Pei Y., Chan C., Cattran D., Cardella C., Zaltzman J., Lopez M., Tong J., Schachter R., Maurer J. Sustained vasoconstriction associated with daily cyclosporine dose in heart and lung transplant recipients potential pathophysiologic role of endothelin . J. Lab. Clin. Med. 125:1995;113-119.
12. Zhang W. W., Badonic T., Hoog A., Jiang M. H., Ma K. C., Nie X. J., Olsson Y. Astrocytes in Alzheimer's disease express immunoreactivity to the vaso-constrictor endothelin-1. J. Neurol. Sci. 122:1994;90-96.
13. Heyl D. L., Cody W. L., He J. X., Flynn M. A., Welch K. M., Reynolds E. E., Doherty A. M. Truncated analogues of endothelin and sarafotoxin are selective for the ETB receptor subtype. Pept. Res. 6:1993;238-241.
14. Panek R. L., Major T. C., Hingorani G. P., Doherty A. M., Taylor D. G., Rapundalo S. T. Endothelin and structurally related analogs distinguish between endothelin receptor subtypes. Biochem. Biophys. Res. Commun. 183:1992;566-571.
15. Haynes W. G., Davenport A. P., Webb D. J. Endothelin progress in pharmacology and physiology . Trends. Pharmacol. Sci. 14:1993;225-228.
16. Baranyi L., Campbell W., Ohshima K., Fujimoto S., Boros M., Okada H. The antisense homology box a new motive in proteins that often codes biologically active peptides . Nature Med. 9:1995;894-901.
17. Baranyi L., Campbell W., Okada H. Antisense homology boxes in C5a receptor and C5a anaphylatoxin. A new method for identification of potentially active peptides. J. Immunol. 157:1996;4591-4601.
18. Merrifield R. B. Solid phase peptide synthesis I. The synthesis of a tetrapeptide . J. Am. Chem. Soc. 85:1963;2149-2154.
19. König W., Geiger R. Eine neue Methode zur Synthese vom Peptiden Aktivierung der Carboxylgruppe mit Dicyclohexacarbodiimid unter Zusatz von 1-Hydroxylbenzotriazolen . Chem. Ber. 103:1978;788-798.
20. Posnett D. N., McGrath H., Tam J. P. A novel method for producing anti-peptide antibodies. J. Biol. Chem. 263:1988;1719-1725.
21. Blalock J. E. Complementarity of peptides specified by 'sense' and 'antisense' strands of DNA. TIBTECH. 6:1991;140-144.
22. Blalock J. E. Genetic origin of protein shape and interaction rules. Nature Med. 9:1995;876-878.
23. Kaiser E. T., Kezdi F. J. Secondary structures of proteins and peptides in amphyphillic environments (a review). Proc. Natl. Acad. Sci. USA. 80:1983;1137-1143.
24. Markus G., Tritsch G. L., Parthasarathy R. A. model for hydropathy-based peptide interaction. Arch. Biochem. Biophys. 272:1989;433-439.
25. Milligan G., Bond R. A., Lee L. Inverse agonism pharmacological curiosity or potential therapeutic strategy . TIBS. 16:1995;10-13.
26. 2-adrenoreceptor. Nature. 374:1995;272-276.
27. Ruiz-Opazo N., Akimoto K., Herrera V. L. M. Identification of a novel dual angiotensin-vasopressin receptor direct evidence for the molecular recognition hypothesis . Nature Med. 8:1995;634-639.
28. A receptor abrogated the binding activity to ET-1. BBRC. 187:1992;1241-1248.
29. Hashido K., Adachi M., Gamou T., Watanabe T., Furuichi Y., Miyamoto C. Identification of specific intracellular domains of the human ETA receptor required for ligand binding and signal transduction. Cell. Mol. Biol. Res. 39:1993;3-12.
30. A receptor required for ligand binding. FEBS. 311:1992;179-183.
31. B. J. Biochem. (Tokyo). 11:1992;748-753.
32. Lee J. A., Elliott J. D., Sutiphong J. A., Friesen W. J., Ohlstein E. H., Stadel J. M., Gleason J. G., Peishoff C. E. Tyr-129 is important to the peptide ligand affinity and selectivity of human endothelin type A receptor. Proc. Natl. Acad. Sci. USA. 91:1994;7164-7168.
33. Shai Y., Brunck T. K., Chaiken I. M. Antisense peptide recognition of sense peptides sequence simplification and evaluation of forces underlying the interaction . Biochemistry. 28:1989;8804-8811.
34. B receptors mediate contraction to endothelin-1 in human blood vessels. Circulation. 89:1994;1203-1208.
35. Fassina G., Consonni R., Zetta L., Cassani G. Design of hydropathically complementary peptides for human big endothelin affinity purification. Int. J. Peptide Prot. Res. 39:1992;540-548.
36. Fassina, G.; Thorgeirson, S. S.; Omichinski, J. G. Sequence directed design of recognition peptides. In: B. Wittman-Liebold, Ed. Methods in protein sequence analysis. Berlin: Springer-Verlag; 1989:431-438.